North Carolina is a leading place for biotech, and a big part of that success comes from GlaxoSmithKline (GSK). This global ...
Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.
UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...
Healthcare decision-makers are facing significant challenges that will intensify in the coming years as they work to address ...
Nigeria’s manufacturing sector is under siege. The cruel combination of high energy costs, foreign exchange scarcity, rising ...
GlaxoSmithKline (GSK) has firmly acquired the number one position in the Egyptian pharmaceutical market since 2009 and is likely to maintain the grip at least until the end of 2011. GSK’s ...
Asthma affects approximately 262 million people globally, with the number of asthma incidents having increased by around 15% ...
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...
WBBM Radio Chicago on MSN5d
Northwestern is suing one of the makers of the COVID-19 vaccinesThe vaccine that’s helped protect millions of people worldwide from the COVID-19 virus and its variants would not have been ...
The rising cost of living continues to hit Nigerian households and the latest example is the price of toothpaste, which is ...
Teva Pharmaceutical Industries Ltd. ADR 1.10% $20.47B ...
GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue ... As on 30-06-2024, the company has a total of 16.94 Crore shares outstanding.GSK Pharma Share Price Today is Rs. 2659.30 as on 18 Oct, 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback